Minerva Neurosciences Inc (NERV)
2.40
+0.06
(+2.56%)
USD |
NASDAQ |
May 07, 10:57
Minerva Neurosciences Cash from Investing (TTM): 0.00 for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | -0.0163M |
June 30, 2023 | -0.0163M |
March 31, 2023 | -0.0163M |
December 31, 2022 | -0.0163M |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 3.00M |
March 31, 2021 | 7.50M |
December 31, 2020 | 24.53M |
September 30, 2020 | 22.22M |
June 30, 2020 | 38.80M |
March 31, 2020 | 41.66M |
December 31, 2019 | 14.08M |
September 30, 2019 | -11.03M |
June 30, 2019 | -1.112M |
March 31, 2019 | 27.62M |
Date | Value |
---|---|
December 31, 2018 | 69.49M |
September 30, 2018 | 96.89M |
June 30, 2018 | -12.41M |
March 31, 2018 | -59.40M |
December 31, 2017 | -107.19M |
September 30, 2017 | -107.16M |
June 30, 2017 | -18.99M |
March 31, 2017 | -6.702M |
December 31, 2016 | 17.82M |
September 30, 2016 | 21.87M |
June 30, 2016 | 14.32M |
March 31, 2016 | -10.28M |
December 31, 2015 | -18.33M |
September 30, 2015 | -22.43M |
June 30, 2015 | -23.29M |
March 31, 2015 | -0.0856M |
December 31, 2014 | 1.087M |
September 30, 2014 | 1.131M |
June 30, 2014 | 1.165M |
March 31, 2014 | 1.165M |
December 31, 2013 | -0.0032M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-11.03M
Minimum
Sep 2019
41.66M
Maximum
Mar 2020
6.979M
Average
--
Median
Sep 2021
Cash from Investing (TTM) Benchmarks
Viking Therapeutics Inc | -641.08M |
Janux Therapeutics Inc | -41.19M |
ACADIA Pharmaceuticals Inc | 32.00M |
Karyopharm Therapeutics Inc | 7.94M |
Calidi Biotherapeutics Inc | -- |